n,n-dimethylarginine has been researched along with Alzheimer Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, Z; Luo, Y; Quan, X; Wang, Y; Yue, W; Zhao, B | 1 |
| Georgakis, MK; Latsios, G; Oikonomou, E; Papageorgiou, N; Papaioannou, S; Siasos, G; Tousoulis, D; Zaromitidou, M | 1 |
| Arlt, S; Böger, RH; Eichenlaub, M; Jahn, H; Lehmbeck, JT; Maas, R; Schulze, F; Schwedhelm, E | 1 |
| Chen, M; Jiang, P; Jiao, BH; Lü, J; Xiang, ZH | 1 |
| Blomberg, M; de Jong, S; Mulder, C; Scheltens, P; Teerlink, T; van Kamp, GJ; Wahlund, LO | 1 |
| Selley, ML | 1 |
| Abe, T; Isobe, C; Murata, T; Sato, C; Tohgi, H | 1 |
1 review(s) available for n,n-dimethylarginine and Alzheimer Disease
| Article | Year |
|---|---|
Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches.
Topics: Alzheimer Disease; Animals; Arginine; Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Hypercholesterolemia; Neoplasms; Pre-Eclampsia; Pregnancy; Renal Insufficiency, Chronic | 2015 |
1 trial(s) available for n,n-dimethylarginine and Alzheimer Disease
| Article | Year |
|---|---|
Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Arginine; Enzyme Inhibitors; Female; Homocysteine; Humans; Male; Matched-Pair Analysis; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Reference Values; Statistics as Topic | 2003 |
5 other study(ies) available for n,n-dimethylarginine and Alzheimer Disease
| Article | Year |
|---|---|
Asymmetric dimethylarginine exacerbates Aβ-induced toxicity and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Arginine; Caenorhabditis elegans; Disease Models, Animal; Gene Knockdown Techniques; Humans; MAP Kinase Signaling System; Oxidative Stress; Protein-Arginine N-Methyltransferases; Repressor Proteins | 2015 |
Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Arginine; Biomarkers; Body Mass Index; Case-Control Studies; Cognition Disorders; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Risk Factors | 2008 |
[The correlation of asymmetrical dimethylarginine level and oxidative stress to the onset of Alzheimer's disease].
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Arginine; Female; Humans; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Peptide Fragments; Peroxynitrous Acid; Reactive Oxygen Species; Tyrosine | 2010 |
Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Arginine; Brain; Cytoskeleton; Dimethylamines; Female; Humans; Male; Middle Aged; Neurons; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Peptide Fragments; tau Proteins | 2002 |
Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease.
Topics: Aged; Aging; Alzheimer Disease; Arginine; Brain; Female; Humans; Male; Middle Aged; Neurons; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress | 2001 |